Skip to main content

Advertisement

SpringerLink
Log in

Changing patterns of etiology and management of hepatocellular carcinoma: need for global reappraisal

  • Letter to the Editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Enomoto H, Ueno Y, Hiasa Y, et al. The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan. J Gastroenterol. 2020. https://doi.org/10.1007/s00535-020-01748-x (Online ahead of print).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ho SY, Liu PH, Hsu CY, et al. Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma. Sci Rep. 2020;10:3925.

    Article  CAS  Google Scholar 

  3. Garuti F, Neri A, Avanzato F, et al. The changing scenario of hepatocellular carcinoma in Italy: an update. Liver Int. 2020. https://doi.org/10.1111/liv.14735 (Online ahead of print).

    Article  PubMed  Google Scholar 

  4. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997;336:1855–9.

    Article  CAS  Google Scholar 

  5. Chiang CJ, Yang YW, You SL, et al. Thirty-year outcomes of the national hepatitis B immunization program in Taiwan. JAMA. 2013;310:974–6.

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported by a Grant (VN110-06) from Taipei Veterans General Hospital, Taiwan.

Author information

Authors and Affiliations

  1. Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan

    Teh-Ia Huo

  2. Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Teh-Ia Huo

  3. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

    Teh-Ia Huo, Shu-Yein Ho & Po-Hong Liu

  4. Division of Gastroenterology and Hepatology, Min-Sheng General Hospital, Taoyuan, Taiwan

    Shu-Yein Ho

  5. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA

    Po-Hong Liu

Authors
  1. Teh-Ia Huo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shu-Yein Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Po-Hong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Guarantor of the article: TIH. Specific author contributions: THH and PHL performed the research. SYH and TIH designed the study and wrote the paper. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Teh-Ia Huo.

Ethics declarations

Conflict of interest statement

There is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huo, TI., Ho, SY. & Liu, PH. Changing patterns of etiology and management of hepatocellular carcinoma: need for global reappraisal. J Gastroenterol 56, 406–407 (2021). https://doi.org/10.1007/s00535-021-01770-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-021-01770-7

Keywords

Search

Navigation